Bibliometric analysis of microRNAs and Parkinson's disease from 2014 to 2023

Lingshan Chen1,2, Jianfei Chen1, Wei Weng1

  • 1Medical Laboratory Specialty, The Second Hospital of Jinhua, Jinhua, Zhejiang, China.

Frontiers in Neurology
|October 10, 2024
PubMed
Abstract

Insights

MicroRNAs (miRNAs) are increasingly linked to Parkinson's disease (PD) research, with studies exploring mechanisms, diagnostics, and therapeutics. This bibliometric analysis reveals key trends and topics in miRNA-PD research from 2014-2023.

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Parkinson's disease (PD) involves dopaminergic neuron degeneration.
  • MicroRNAs (miRNAs) show a significant correlation with PD.
  • Understanding miRNA's role is crucial for PD research.

Purpose of the Study:

  • Conduct a bibliometric analysis of miRNA involvement in PD (2014-2023).
  • Identify key research areas and current trends.
  • Propose future research directions.

Main Methods:

  • Collected literature from Web of Science Core Collection.
  • Analyzed data using Bibliometrix R package and VOSviewer.
  • Focused on publications from 2014 to 2023.

Main Results:

  • Annual publications on miRNAs and PD show a 12.67% growth rate.
  • China, USA, and India are top publishing countries.
  • Keywords include alpha-synuclein, neuroinflammation, oxidative stress, autophagy, and emerging topics like ceRNA and circular RNA.

Conclusions:

  • Bibliometric analysis highlights diverse and evolving miRNA-PD research.
  • Research focuses on mechanisms, diagnostic markers, and therapeutic strategies.
  • Findings guide future research in this domain.